
Emkay has released a report pointing out that the rupee-led fears which have led to under-performance of Pharma stocks are overblown and that this is an opportunity for investors to buy high-quality stocks
Today, when investors thronged the counters of SBI and the other PSU Banks and sent their stock prices spiraling up, giving a 6 month return of 56%, Tabassum Inamdar of Goldman Sachs knew that her bet had paid off big time
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Rakesh Jhunjhunwala
Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala
Recent Comments